Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration. (Q50724125)
Jump to navigation
Jump to search
scientific article published on 7 July 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration. |
scientific article published on 7 July 2006 |
Statements
Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration. (English)
1 reference
VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N.) Clinical Trial Group
1 reference
U Chakravarthy
1 reference
A P Adamis
1 reference
E T Cunningham
1 reference
M Goldbaum
1 reference
D R Guyer
1 reference
B Katz
1 reference
Manju Patel
1 reference
7 July 2006
1 reference
113
1 reference
9
1 reference
1508.e1-25
1 reference